Raymond James Financial’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Raymond James Financial’s Portfolio IHE Stock Details IHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$5.78M	Buy	66,738 +10,673	+19%	+$934K	﹤0.01%	2472
2025 Q4	$4.76M	Buy	56,065 +1,421	+3%	+$113K	﹤0.01%	2555
2025 Q3	$3.96M	Sell	54,644 -8,920	-14%	-$615K	﹤0.01%	2629
2025 Q2	$4.17M	Buy	63,564 +1,955	+3%	+$127K	﹤0.01%	2497
2025 Q1	$4.35M	Sell	61,609 -6,443	-9%	-$448K	﹤0.01%	2431
2024 Q4	$4.47M	Buy	+68,052	New	+$4.68M	﹤0.01%	2394

Other funds holding IHE

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

FIA

Foundations Investment Advisors Phoenix, Arizona $8.07B AUM 24.97% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

ACA

Aptus Capital Advisors Fairhope, Alabama $12.7B AUM 17.41% 1-Year Est. Return

MSCM

McElhenny Sheffield Capital Management Dallas, Texas $403M AUM 28.73% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

ACM

Anfield Capital Management Irvine, California $363M AUM 24.08% 1-Year Est. Return

IWS

Insight Wealth Strategies San Ramon, California $1.02B AUM 38% 1-Year Est. Return

Raymond James Financial's IHE Position: Q1 2026 in Review

Raymond James Financial increased its iShares US Pharmaceuticals ETF (IHE) stake by 19% in Q1 2026, buying an estimated $934K and bringing the position to 66,738 shares worth $5.78M. The position accounts for ﹤0.01% of the portfolio, ranked #2472.

Raymond James Financial first reported a position in IHE in Q4 2024 and has held it in 6 quarters since. 194 funds tracked by Wall St. Rank hold IHE as of Q1 2026.

Raymond James Financial held 66,738 shares of iShares US Pharmaceuticals ETF worth $5.78M as of Q1 2026.
Raymond James Financial bought 10,673 iShares US Pharmaceuticals ETF shares in Q1 2026, an estimated $934K.
iShares US Pharmaceuticals ETF made up ﹤0.01% of Raymond James Financial's portfolio in Q1 2026, its #2472 holding.
Raymond James Financial first reported a position in iShares US Pharmaceuticals ETF in Q4 2024 and has held it in 6 quarters since.
194 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q1 2026.

Based on Raymond James Financial's 13F filing for Q1 2026, filed 14 May 2026.